QD146 - Combination Biologics

Infections in Psoriasis Patients Treated with Small Molecules, Biologics or the CombinationПодробнее

Positioning immunomodulators as monotherapies or in combination with biologicsПодробнее

When and How to Use Immunomodulators and Biologics in IBDПодробнее

Beyond Combination Therapy in IBD: What Have We Learned?Подробнее

Should We Change How we Position Biologics for Use in Crohn’s Disease?Подробнее

The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging AgentsПодробнее

QD146 - Anti-IntraarticularПодробнее

RheumNow Podcast – Combination Biologics (4.16.2021)Подробнее

How Can We Prevent and Manage the Common Side Effects of Immunomodulators and Biologics?Подробнее

The treatment of moderate to severe IBD with anti-TNF biologics and immunomodulatorsПодробнее

Positioning of Biologics and New Therapeutics for Crohn's DiseaseПодробнее

Understanding the Contraindications to the Use of Immunomodulators and Biologics for IBDПодробнее

Treating IBD: BiologicsПодробнее

Positioning of Biologics in the ClinicПодробнее

Combo of RG6146/venetoclax/rituximab for R/R DLBCL: initial dataПодробнее

Positioning of Biologics and New Therapeutics for Ulcerative ColitisПодробнее

Part 1: Best of ACR 2021Подробнее

Biologics: Indications and ApproachesПодробнее

Biologic Therapy Should Never Be Stopped, or Should It?Подробнее